文献速递主动脉疾病外周动脉疾病内脏/肾动脉与血管畸形

肱动脉入路用于血管内干预的结局分析

Outcomes of Brachial Artery Access for Endovascular Interventions.
PubMed 文献 · Ann Vasc Surg · 2018-10-19

单中心回顾分析2003年1月1日至2017年12月31日136例患者共157例次非心脏血管内干预的肱动脉入路结局。经皮穿刺142例次,穿刺点并发症发生率10.6%(15/142),需开放手术处理出血8例和肱动脉血栓7例;鞘管增大并发症风险有升高趋势但无统计学差异(P=0.49)。作者建议需6或7F鞘管时更积极采用开放手术暴露和肱动脉一期修复。

要点

  • 经皮肱动脉入路穿刺点并发症发生率为10.6%(15/142),出血与血栓例数相近。
  • 5F、6F、7F鞘管并发症发生率分别为5.4%(2/37)、12.4%(11/89)、12.5%(2/16),P=0.49。
  • 作者建议需6或7F鞘管经肱动脉入路时更积极采用开放手术暴露和肱动脉一期修复。

核心结论

  • 作者经验中经皮肱动脉入路并发症发生率为10%,鞘管增大与并发症风险升高相关。
  • 作者建议需6或7F鞘管经肱动脉入路时更积极采用开放手术暴露和肱动脉一期修复。

研究设计与样本

  • 单中心分析2003年1月1日至2017年12月31日136例患者共157例次非心脏血管内干预的肱动脉入路结局。
  • 手术包括治疗性干预102例次(65%)和诊断性检查55例次(35%)。

主要发现

  • 经皮穿刺142例次(90.4%),计划开放手术暴露并一期修复肱动脉15例次(9.6%)。
  • 围术期死亡2例(1.3%;2/157),一例死于心肌梗死,另一例死于肠系膜缺血。
  • 经皮穿刺病例穿刺点并发症15/142(10.6%),需开放手术处理出血8例和肱动脉血栓7例。
  • 经皮入路并发症风险随鞘管增大而升高:5F为5.4%(2/37)、6F为12.4%(11/89)、7F为12.5%(2/16),P=0.49。
  • 接受手术治疗的15例患者均未出现长期血管或神经并发症。

临床怎么用

  • 作者认为经皮肱动脉入路并发症发生率为10%,鞘管增大与并发症风险升高相关。
  • 作者建议需6或7F鞘管经肱动脉入路时更积极采用开放手术暴露和肱动脉一期修复。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A percutaneous brachial artery (BA) approach is a suitable or even favorable alternative to femoral artery access when performing certain endovascular interventions. However, this approach may have a higher complication rate compared to femoral artery access. We analyzed our results using percutaneous BA approach for noncardiac endovascular interventions. METHODS: Between January 1, 2003 and December 31, 2017, BA access was used in 157 cases performed on 136 patients. The procedures included 102 (65%) therapeutic interventions and 55 (35%) diagnostic studies. The vessels studied or treated included lower extremity arteries (48), the aorta and iliac arteries (45), mesenteric arteries (45), failing arterial revascularizations (24), renal arteries (9), subclavian arteries (8), carotid arteries (2), and visceral aneurysms (2), or in conjunction with endovascular aneurysm repair (EVAR), fenestrated EVAR, or thoracic EVAR (8). More than 1 vessel was studied or treated in 34 cases. Sheath sizes included 5F in 38 (24%) cases, 6F in 93 (59%) cases, and 7F in 26 (17%) cases. Percutaneous puncture was utilized in 142 (90.4%) cases and planned surgical exposure with primary closure of the BA in 15 (9.6%) cases (10, 7F; 4, 6F; 1, 5F). Manual compression was used for hemostasis at the conclusion of all percutaneous cases. RESULTS: There were 2 (1.3%; 2/157 cases) deaths in the perioperative period, one due to myocardial infarction and the other from mesenteric ischemia. Access site complications occurred in 10.6% (15/142) of percutaneous cases, which required open surgical repair for bleeding (8) and BA thrombosis (7). There was an increased risk of complications with increasing sheath size in the percutaneous approach: 5.4% (2/37), 12.4% (11/89), and 12.5% (2/16) for 5F, 6F, and 7F sheaths, respectively (P = 0.49). None of the 15 patients who underwent surgical treatment suffered long-term vascular or neuropathic complications. CONCLUSIONS: In our experience, percutaneous BA access was associated with a 10% complication rate with an increased risk of complications associated with increasing sheath size. There was approximately the same incidence of bleeding as thrombosis. For patients who require 6 or 7F sheaths via a BA approach, we recommend more liberal use of open surgical exposure and primary BA repair.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Madden NJ, Calligaro KD, Zheng H, et al. Outcomes of Brachial Artery Access for Endovascular Interventions. Ann Vasc Surg. 2018. PMID: 30347242. doi:10.1016/j.avsg.2018.07.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。